Curis
CRIS
#10182
Rank
โ‚น1.27 B
Marketcap
โ‚น93.08
Share price
0.00%
Change (1 day)
-59.87%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น338.22. In 2024 the company made an earnings per share (EPS) of -โ‚น647.87 an increase over its 2023 EPS that were of -โ‚น832.19.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-51.24%
2024-โ‚น647.87-22.15%
2023-โ‚น832.19-26.17%
2022-โ‚น1,12722.3%
2021-โ‚น921.58-25.37%
2020-โ‚น1,235-30.93%
2019-โ‚น1,788-2.02%
2018-โ‚น1,825
2016-โ‚น4,147-10%
2015-โ‚น4,608138.1%
2014-โ‚น1,93540%
2013-โ‚น1,382-25%
2012-โ‚น1,84366.67%
2011-โ‚น1,106

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.33-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น273.71-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น33.18-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น219.34-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น311.49-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,036 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น129.94-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA